Ebola Vaccines: FDA Advisory Committee Convenes As Outbreak Recedes
This article was originally published in The Pink Sheet Daily
Challenge of testing vaccines when infections seem to be coming under control is among potential issues for May 12 meeting.
You may also be interested in...
Along with adding Ebola to list of disease treatments eligible for tropical disease priority review voucher, bill moving through Congress would cut notification time required before redemption.
FDA expects few people would get the disease in the U.S., but many could receive a vaccine.
CBER Director Peter Marks said more sophisticated manufacturing expected in the next decade could lead to questions about whether gene therapies should be regulated by his center or CDRH.